ImmunoPrecise AI Platform LENSai™ Aligns with FDA’s New Policy
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced its strong...
Oxford Nanopore Expands Compatible Products Programme
Multiple new partnerships with approved products announced to support broader access to flexible, end-to-end sequencing...
eXoZymes Launches BioClick with $300K NIH Grant
Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform...
Inbiome’s IVDR-Certified Test IDs Bacteria in 5 Hours
Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals Inbiome, a...
Insight Health and Office Practicum Partner to Transform Docs with AI
New white-labeled solution “Opie AI” enhances pediatric workflows to reduce administrative burden and improve quality...
Kensington Private Hospital Sets New Standard with Provation MD
Kensington Private Hospital has implemented Provation® MD, a market-leading GI procedure documentation solution. This transition marks...